Insider · CIK 0001367998

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

Reports to the SEC for 5 companies · THE WOODLANDS, TX

sec.gov

Transactions

Companies

Filings

CIK

0001367998

Forms 4 and 5

Insider transactions

29 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-11-27	Corium International, Inc.U Disposition from Tender	10% Owner	UDisposition from Tender	−9.35M sh	$12.50	−$117M	0
2012-11-01	ENDOLOGIX INC /DE/S Sale	10% Owner	SSale	−1.25M sh	$13.17	−$16.5M	1,165,428
2012-09-11	ENDOLOGIX INC /DE/S Sale	10% Owner	SSale	−258K sh	$12.18	−$3.14M	2,204,128
2012-09-10	ENDOLOGIX INC /DE/S Sale	10% Owner	SSale	−204K sh	$12.10	−$2.47M	2,462,210
2012-09-06	ENDOLOGIX INC /DE/S Sale	10% Owner	SSale	−1.54M sh	$12.14	−$18.7M	2,666,020
2012-03-02	Horizon Therapeutics Public Ltd CoP Purchase	10% Owner	PPurchase	+2.76M sh	$3.59	+$9.91M	5,064,731
2012-03-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Common StockC Conversion	10% Owner	CConversion	+690K sh	$0.03	+$21.6K	690,369
2012-02-28	ENDOLOGIX INC /DE/S Sale	10% Owner	SSale	−490K sh	$13.18	−$6.46M	4,204,128
2012-02-27	ENDOLOGIX INC /DE/S Sale	10% Owner	SSale	−760K sh	$12.67	−$9.63M	4,694,028
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	10% Owner	CConversion	+1.43M sh	—	—	1,431,467
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	10% Owner	CConversion	+179K sh	—	—	1,610,784
2011-08-02	Horizon Therapeutics Public Ltd CoC Conversion	10% Owner	CConversion	+362K sh	$9.00	+$3.26M	1,973,150
2011-08-02	Horizon Therapeutics Public Ltd CoP Purchase	10% Owner	PPurchase	+330K sh	$9.00	+$2.97M	2,303,254
2011-08-02	Horizon Therapeutics Public Ltd CoSeries A Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.43M sh	—	—	0
2011-08-02	Horizon Therapeutics Public Ltd CoSeries B Convertible Preferred StockC Conversion	10% Owner	CConversion	−179K sh	—	—	0
2011-08-02	Horizon Therapeutics Public Ltd CoConvertible Promissory NotesC Conversion	10% Owner	CConversion	—	—	—	0
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Series A Preferred StockC Conversion	10% Owner	CConversion	−68K sh	—	—	0
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Series A Preferred StockC Conversion	10% Owner	CConversion	−34K sh	—	—	0
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Series A Preferred StockC Conversion	10% Owner	CConversion	−42.5K sh	—	—	0
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Common StockC Conversion	10% Owner	CConversion	+28.6K sh	—	—	28,630
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Common StockC Conversion	10% Owner	CConversion	+14.3K sh	—	—	14,315
2011-08-02	Horizon Therapeutics Public Ltd CoWarrant to Purchase Common StockC Conversion	10% Owner	CConversion	+17.9K sh	—	—	17,895
2011-06-27	ORTHOVITA INCU Disposition from Tender	10% Owner	UDisposition from Tender	−9.63M sh	$3.85	−$37.1M	0
2009-08-06	LA JOLLA PHARMACEUTICAL COS Sale	10% Owner	SSale	−438K sh	$0.18	−$80.2K	0
2009-08-05	LA JOLLA PHARMACEUTICAL COS Sale	10% Owner	SSale	−623K sh	$0.19	−$117K	437,593
2009-02-26	LA JOLLA PHARMACEUTICAL COS Sale	10% Owner	SSale	−3.33M sh	$0.05	−$172K	1,060,620
2009-02-25	LA JOLLA PHARMACEUTICAL COS Sale	10% Owner	SSale	−1.72M sh	$0.06	−$109K	4,389,366
2009-02-24	LA JOLLA PHARMACEUTICAL COS Sale	10% Owner	SSale	−1.7M sh	$0.07	−$126K	6,107,103
2008-10-22	ORTHOVITA INCP Purchase	10% Owner	PPurchase	+2,500 sh	$2.28	+$5,700	9,596,367

Recent filings

Accepted (ET)
Nov 294
ESSEX WOODLANDS HEALTH VENTURES FUND VII LP0001567619-18-007099
SEC(opens sec.gov)
Nov 54
ENDOLOGIX INC /DE/0001367998-12-000003
SEC(opens sec.gov)
Sep 124
ENDOLOGIX INC /DE/0001367998-12-000002
SEC(opens sec.gov)
Sep 74
ENDOLOGIX INC /DE/0001367998-12-000001
SEC(opens sec.gov)
Mar 54
HORIZON PHARMA, INC.0001181431-12-014350
SEC(opens sec.gov)
Feb 294
ENDOLOGIX INC /DE/0001181431-12-013026
SEC(opens sec.gov)
Aug 44
HORIZON PHARMA, INC.0001209191-11-042504
SEC(opens sec.gov)

Companies

Address

21 WATERWAY AVENUE, SUITE 225

THE WOODLANDS, TX, 77380